Market capitalization | $13.83m |
Enterprise Value | $364.59m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 2.15 |
P/S ratio (TTM) P/S ratio | 0.08 |
P/B ratio (TTM) P/B ratio | negative |
Revenue growth (TTM) Revenue growth | -31.37% |
Revenue (TTM) Revenue | $169.19m |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
5 Analysts have issued a Cutera, Inc. forecast:
5 Analysts have issued a Cutera, Inc. forecast:
Jun '24 |
+/-
%
|
||
Revenue | 169 169 |
31%
31%
|
|
Gross Profit | 27 27 |
78%
78%
|
|
EBITDA | -121 -121 |
117%
117%
|
EBIT (Operating Income) EBIT | -136 -136 |
100%
100%
|
Net Profit | -137 -137 |
79%
79%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Cutera, Inc. sells aesthetic medical equipment and services, and distributes skincare products, to medical practitioners. The firm designs, develops, manufactures, distributes and markets light and energy-based product platforms for use by physicians and other practitioners, enabling them to offer safe and effective aesthetic treatments to customers. Its products include enlighten, excel HR, excel V, excel V+, Juliet, Secret RF, truSculpt flex, truSculpt iD, truSculpt 3D and xeo. The company was founded by David A. Gollnick in August 1998 and is headquartered in Brisbane, CA.
Head office | United States |
CEO | Taylor Harris |
Employees | 430 |
Founded | 1998 |
Website | www.cutera.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.